Science Explorer Back to mapMap

Most cited papers from Intas Pharmaceuticals (India)

What are the most cited papers from Intas Pharmaceuticals (India)?

The most cited paper from Intas Pharmaceuticals (India) is "Ferroptosis of tumour neutrophils causes immune suppression in cancer" (Rina Kim et al., 2022), with 563 citations. Next come "A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate" (193) and "The H1 lead/scintillating-fibre calorimeter" (178).

Showing 50 of 62 papers. Every paper with more than 14 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Ferroptosis of tumour neutrophils causes immune suppression in cancer Rina Kim et al. · Nature Open access 16 Nov 2022 563
2 A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate Lorena Sánchez-Felipe et al. · Nature Open access Dec 2020 193
3 The H1 lead/scintillating-fibre calorimeter R.D. Appuhn et al. · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment Feb 1997 178
4 Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic®P85, anin vitrocell line andin vivobiodistribution studies on rat model Neha B. Shah, Kiran Chaudhari, Prudhviraju Dantuluri et al. · Journal of drug targeting 16 Jun 2009 110
5 Horsepower with Brains: The Design of the CHIRON Free Piston Engine Peter A. J. Achten, Johan P. J. Van Den Oever, Jeroen Potma et al. · SAE technical papers on CD-ROM/SAE technical paper series Conference paper 11 Sep 2000 105
6 Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu et al. · Vaccines Open access 13 Feb 2023 84
7 Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: Current advancement and future breakthroughs Namdev L. Dhas, Ritu R. Kudarha, Atul Garkal et al. · Journal of Controlled Release 18 Dec 2020 82
8 Endoxifen, a New Cornerstone of Breast Cancer Therapy: Demonstration of Safety, Tolerability, and Systemic Bioavailability in Healthy Human Subjects A Ahmad, Syed Khurram Shahabuddin, S Sheikh et al. · Clinical Pharmacology & Therapeutics 27 Oct 2010 81
9 Prevalence, pattern and perceptions of self-medication in medical students Rushi N. Pandya, Kunal S Jhaveri, Falgun Vyas et al. · International Journal of Basic & Clinical Pharmacology Open access 2013 75
10 Performance of an electromagnetic lead/scintillating-fibre calorimeter for the H1 detector T. Nicholls et al. · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment Open access May 1996 67
11 The Innas Hydraulic Transformer The Key to the Hydrostatic Common Pressure Rail Georges E. M. Vael, Peter A. J. Achten, Zhao Qi Fu · SAE technical papers on CD-ROM/SAE technical paper series Conference paper 11 Sep 2000 67
12 Therapeutic monoclonal antibodies for COVID-19 management: an update Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara et al. · Expert Opinion on Biological Therapy 23 May 2022 65
13 A review on multivesicular liposomes for pharmaceutical applications: preparation, characterization, and translational challenges Akash Chaurasiya, Amruta Gorajiya, Kanan Panchal et al. · Drug Delivery and Translational Research Oct 2021 62
14 Effects of Hydrogen Peroxide (H2O2) on Fresh and Cryopreserved Buffalo Sperm Functions During Incubation at 37°CIn Vitro Abhishek Garg, A. Kumaresan, M.R. Ansari · Reproduction in Domestic Animals 12 Nov 2009 59
15 Real-Life Clinical Effectiveness of Razumab® (the World’s First Biosimilar of Ranibizumab) in Retinal Vein Occlusion: A Subgroup Analysis of the Pooled Retrospective RE-ENACT Study Shashikant Sharma, Mujtaba Ali Khan, Alok Chaturvedi et al. · Ophthalmologica Open access 26 Jun 2018 54
16 Application of Peanut Butter to Improve the Nutritional Quality of Cookies P. N. Timbabadiya, S. B. Bheda, Harsukh Popatbhai Gajera et al. · Current Research in Nutrition and Food Science Journal Open access 25 Oct 2017 50
17 Stimuli responsive and receptor targeted iron oxide based nanoplatforms for multimodal therapy and imaging of cancer: Conjugation chemistry and alternative therapeutic strategies Namdev L. Dhas, Ritu R. Kudarha, Abhijeet P. Pandey et al. · Journal of Controlled Release 23 Mar 2021 49
18 Rational Selection, Criticality Assessment, and Tiering of Quality Attributes and Test Methods for Analytical Similarity Evaluation of Biosimilars Kristof Vandekerckhove, Andreas Seidl, Hiten J. Gutka et al. · The AAPS Journal Open access 10 May 2018 47
19 The Combustion Process in a DI Diesel Hydraulic Free Piston Engine Joop Somhorst, Peter A. J. Achten · SAE technical papers on CD-ROM/SAE technical paper series Conference paper Feb 1996 45
20 Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder Ateeq Ahmad et al. · Bipolar Disorders 26 Dec 2020 43
21 A Multicenter, Retrospective Study (RE-ENACT 2) on the Use of Razumab™ (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration Shashikant Sharma, Mujtaba Ali Khan, Alok Chaturvedi et al. · Ophthalmology and Therapy Open access 27 Dec 2019 41
22 Screening for In Vitro Antimycobacterial Activity and Three‐Dimensional Quantitative Structure–Activity Relationship (3D‐QSAR) Study of 4‐(arylamino)coumarin Derivatives Vijay Virsdoia, Mushtaque S. Shaikh, Atul T. Manvar et al. · Chemical Biology & Drug Design 9 Sep 2010 39
23 Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants Vivek P. Chavda, Disha Valu, Palak K. Parikh et al. · Vaccines Open access 6 Feb 2023 38
24 Therapeutic Efficacy of a Novel Nanosomal Docetaxel Lipid Suspension Compared With Taxotere in Locally Advanced or Metastatic Breast Cancer Patients Ateeq Ahmad, Saifuddin Sheikh, Rakesh Taran et al. · Clinical Breast Cancer 28 Sep 2013 38
25 Formulation development and evaluation of medicated chewing gum of anti-emetic drug Mansi Paradkar, Balaram Gajra, Bhautik V Patel · Saudi Pharmaceutical Journal Open access 5 Apr 2015 38
26 Key Design Features of Lipid Nanoparticles and Electrostatic Charge-Based Lipid Nanoparticle Targeting Vijay Gyanani, Roshan Goswami · Pharmaceutics Open access 7 Apr 2023 37
27 Endoxifen, a New Treatment Option for Mania: A Double‐Blind, Active‐Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen A Ahmad, S Sheikh, Tithi S. Shah et al. · Clinical and Translational Science Open access 27 Jun 2016 37
28 Health-Related Quality of Life and Rehabilitation Cost Following Intensive Care Unit Stay in Multiple Trauma Patients Pantelis I Stergiannis, Theodoros A. Katsoulas, George Fildissis et al. · Journal of Trauma Nursing May 2014 34
29 Principles for Health Information Collection, Sharing, and Use: A Policy Statement From the American Heart Association Kayte Spector‐Bagdady, Antonis A. Armoundas, Rima Arnaout et al. · Circulation Open access 30 Aug 2023 32
30 Self-emulsifying delivery systems: one step ahead in improving solubility of poorly soluble drugs Vivek P. Chavda, Dhaval A. Shah · Elsevier eBooks Book chapter 2017 31
31 A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion Shashikant Sharma et al. · Ophthalmology and Therapy Open access 2 Jul 2020 28
32 Comprehensive depiction of novel heavy metal tolerant and EPS producing bioluminescent Vibrio alginolyticus PBR1 and V. rotiferianus PBL1 confined from marine organisms Paritosh Parmar, Arpit Shukla, Dweipayan Goswami et al. · Microbiological Research Open access 18 Jun 2020 28
33 Lactulose: a prebiotic, laxative and detoxifying agent Pranami Dhiren, Ramandeep Sharma, Hardik Pathak · Drugs & Therapy Perspectives 16 Feb 2017 27
34 Therapeutic rationale for low dose doxepin in insomnia patients Jigar Katwala, Ananda K Kumar, Jaykumar J Sejpal et al. · Asian Pacific Journal of Tropical Disease Open access 19 Jul 2013 27
35 Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus Anand Khedkar, Harold E. Lebovitz, Alexander Fleming et al. · Clinical Pharmacology in Drug Development Open access 7 Aug 2019 26
36 Pharmacovigilance of biosimilars – Why is it different from generics and innovator biologics? B Oza, Swetha Radhakrishna, Parag Pipalava et al. · Journal of Postgraduate Medicine Open access 2019 25
37 Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis Sagar Salave, Suchita Dattatray Shinde, Dhwani Rana et al. · Pharmaceutics Open access 11 Feb 2023 23
38 [Experts' Opinion] Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer Senthil Jagannathan Rajappa, Ashish Joshi, Dinesh Chandra Doval et al. · Oncology Letters Open access 2 Jul 2018 23
39 Intranasal transmucosal drug delivery: An alternative approach to the parenteral route for medical emergencies Jyotsna G. Vitore, K. Bharathi, Sagar Salave et al. · Journal of Drug Delivery Science and Technology 5 Apr 2023 22
40 Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia et al. · Process Biochemistry Open access 31 Jan 2023 22
41 Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study Shashikant Sharma, Vishali Gupta, Aniruddha Maiti et al. · International Journal of Retina and Vitreous Open access 24 Mar 2021 22
42 Doceaqualip in a patient with prostate cancer who had an allergic reaction to conventional docetaxel: A case report Radheshyam Naik, Mujtaba Ali Khan · Molecular and Clinical Oncology Open access 2 Feb 2017 22
43 DESIGN AND FUEL ECONOMY OF A SERIES HYDRAULIC HYBRID VEHICLE Peter A. J. Achten, Georges E. M. Vael, Mohamed Sokar et al. · Proceedings of the JFPS International Symposium on Fluid Power Conference paperOpen access 2008 22
44 Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS). Upendra Kaul, Jagmohan Varma, Dhiman Kahali et al. · PubMed Feb 2013 22
45 Polyoxyl 60 hydrogenated castor oil free nanosomal formulation of immunosuppressant Tacrolimus: Pharmacokinetics, safety, and tolerability in rodents and humans Shoukath M. Ali, Ateeq Ahmad, Saifuddin Sheikh et al. · International Immunopharmacology 22 Dec 2009 22
46 Structural similarity, characterization of Poly Ethylene Glycol linkage and identification of product related variants in biosimilar pegfilgrastim Rakesh Shekhawat, Chintan Kumar Shah, Akash Patel et al. · PLoS ONE Open access 13 Mar 2019 21
47 A retrospective regulatory analysis of FDA recalls carried out by pharmaceutical companies from 2012 to 2023 Ravi Bharatkumar Patel, Ravi Bharatkumar Patel, Aksha Vhora et al. · Drug Discovery Today Open access 25 Apr 2024 20
48 Development and validation of an analytical method for trace‐level quantification of genotoxic nitrosamine impurities in losartan and hydrochlorothiazide fixed‐dose combination tablets using ultra performance liquid chromatography triple quadrupole mass spectrometry Ravi Bharatkumar Patel, Ravi Bharatkumar Patel, Sanjay Purohit et al. · Rapid Communications in Mass Spectrometry Open access 6 Feb 2023 20
49 Structural Elucidation of Alkali Degradation Impurities of Favipiravir from the Oral Suspension: UPLC-TQ-ESI-MS/MS and NMR Ravi Bharatkumar Patel, Abhishek Dube, Ravisinh Vikramsinh Solanki et al. · Molecules Open access 31 Aug 2022 20
50 Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery Anand Krishnan, Prakash Gangadaran, Vivek P. Chavda et al. · Experimental Biology and Medicine Open access 13 May 2022 20

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.